Five Oceans Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
CWP
FWIA
ORIO
CNB
KC
WAM
Five Oceans Advisors's PFE Position: Q2 2026 in Review
Five Oceans Advisors reduced its Pfizer (PFE) stake by 8.8% in Q2 2026, selling an estimated $21.1K and leaving 8,388 shares worth $202K. The position accounts for 0.06% of the portfolio, ranked #201.
Five Oceans Advisors first reported a position in PFE in Q3 2021 and has held it in 19 quarters since. The position peaked at $440K in Q4 2021. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Five Oceans Advisors held 8,388 shares of Pfizer worth $202K as of Q2 2026.
- Five Oceans Advisors sold 808 Pfizer shares in Q2 2026, an estimated $21.1K.
- Pfizer made up 0.06% of Five Oceans Advisors's portfolio in Q2 2026, its #201 holding.
- Five Oceans Advisors first reported a position in Pfizer in Q3 2021 and has held it in 19 quarters since.
- Five Oceans Advisors's Pfizer position peaked at $440K in Q4 2021.
- 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Five Oceans Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.